Science Explorer Back to mapMap

Most cited papers from Agaplesion Markus Hospital

What are the most cited papers from Agaplesion Markus Hospital?

The most cited paper from Agaplesion Markus Hospital is "STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD" (Dan Turner, Amanda Ricciuto, Ayanna E. Lewis et al., 2021), with 2,882 citations. Next come "3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management" (2,100) and "Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management" (1,558).

Showing 50 of 60 papers. Every paper with more than 157 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD Dan Turner, Amanda Ricciuto, Ayanna E. Lewis et al. · Gastroenterology Open access 20 Feb 2021 2,882
2 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management Fernando Gomollón et al. · Journal of Crohn s and Colitis Open access 22 Sep 2016 2,100
3 Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management Axel U Dignass, James Oliver Lindsay, Andreas Sturm et al. · Journal of Crohn s and Colitis 3 Oct 2012 1,558
4 The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management Axel U Dignass, Gert Van Assche, James Oliver Lindsay et al. · Journal of Crohn s and Colitis 16 Jan 2010 1,501
5 Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management Marcus Harbord, Rami Eliakim, Dominik Bettenworth et al. · Journal of Crohn s and Colitis Open access 28 Jan 2017 1,194
6 Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial Julián Panés, Damián García‐Olmo, Gert Van Assche et al. · The Lancet 29 Jul 2016 1,098
7 Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease Frank M. Ruemmele et al. · Journal of Crohn s and Colitis Open access 6 Jun 2014 1,090
8 Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial Gϋnter von Minckwitz et al. · The Lancet Oncology 30 Apr 2014 1,048
9 Benchmarking Complications Associated with Esophagectomy Donald E. Low et al. · Annals of Surgery Open access 5 Dec 2017 903
10 The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations Gert Van Assche et al. · Journal of Crohn s and Colitis Open access 22 Dec 2009 901
11 Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis Axel U Dignass, Rami Eliakim, Fernando Magro et al. · Journal of Crohn s and Colitis 3 Oct 2012 897
12 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 2: Surgical Management and Special Situations Paolo Gionchetti, Axel U Dignass, Silvio Danese et al. · Journal of Crohn s and Colitis Open access 22 Sep 2016 780
13 Heavy-ion tumor therapy: Physical and radiobiological benefits Dieter Schardt, Thilo Elsässer, Daniela Schulz–Ertner · Reviews of Modern Physics 19 Feb 2010 768
14 European Consensus on the Diagnosis and Management of Iron Deficiency and Anaemia in Inflammatory Bowel Diseases Axel U Dignass, Christoph Gasché, Dominik Bettenworth et al. · Journal of Crohn s and Colitis Open access 4 Dec 2014 623
15 Meta-Analysis of Genome-Wide Association Studies in >80 000 Subjects Identifies Multiple Loci for C-Reactive Protein Levels Abbas Dehghan et al. · Circulation ReviewOpen access114 authors 8 Feb 2011 525
16 Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management Maria Domenica Cappellini, Josep Comín‐Colet, Angel de Francisco et al. · American Journal of Hematology Open access 14 Jun 2017 512
17 Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn’s Disease Julián Panés et al. · Gastroenterology Open access 23 Dec 2017 496
18 Diagnosis and management of acute appendicitis. EAES consensus development conference 2015 Ramon R. Gorter et al. · Surgical Endoscopy Open access 22 Sep 2016 476
19 Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations Gert Van Assche, Axel U Dignass, Bernd Bokemeyer et al. · Journal of Crohn s and Colitis 3 Oct 2012 468
20 Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases# Christoph Gasché, Arnold Berstad, Ragnar Befrits et al. · Inflammatory Bowel Diseases 5 Nov 2007 453
21 European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies Vito Annese, Laurent Beaugerie, Laurence John Egan et al. · Journal of Crohn s and Colitis Open access 20 Aug 2015 428
22 Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study Luca Gianni, Chiun‐Sheng Huang, Daniel Egle et al. · Annals of Oncology Open access 16 Feb 2022 405
23 Management of Pediatric Ulcerative Colitis Dan Turner et al. · Journal of Pediatric Gastroenterology and Nutrition Sep 2012 384
24 Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours U.-F. Pape, Uta Berndt, Jacqueline Müller‐Nordhorn et al. · Endocrine Related Cancer Open access 4 Jul 2008 384
25 Spatial predictors of immunotherapy response in triple-negative breast cancer Xiao Qian Wang et al. · Nature Open access 6 Sep 2023 361
26 The 2018 ISDE achalasia guidelines Giovanni Zaninotto et al. · Diseases of the Esophagus Open access 30 Aug 2018 358
27 Peroral Endoscopic Myotomy for the Treatment of Achalasia: An International Prospective Multicenter Study Daniel von Renteln, Karl–Hermann Fuchs, Paul Fockens et al. · Gastroenterology Open access 9 May 2013 341
28 Peroral Endoscopic Myotomy for the Treatment of Achalasia: A Prospective Single Center Study Daniel von Renteln, Haruhiro Inoue, Hiromi Minami et al. · The American Journal of Gastroenterology 8 Nov 2011 341
29 Epithelial restitution and wound healing in inflammatory bowel disease Andreas Sturm, Axel U Dignass · World Journal of Gastroenterology Open access 2008 335
30 Evidence for abnormal calcium homeostasis in patients with adynamic bone disease Peter Kurz, Marie-Claude Monier-Faugere, Benedek Bognar et al. · Kidney International Open access Sep 1994 330
31 Axillary Surgery in Breast Cancer — Primary Results of the INSEMA Trial Toralf Reimer et al. · New England Journal of Medicine 12 Dec 2024 307
32 Diagnosis and management of iron deficiency anemia in patients with IBD Jürgen M. Stein, Franz S. Hartmann, Axel U Dignass · Nature Reviews Gastroenterology & Hepatology Review 5 Oct 2010 305
33 Effect of neoadjuvant anthracycline–taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study Jens Huober, Gϋnter von Minckwitz, Carsten Denkert et al. · Breast Cancer Research and Treatment 9 Aug 2010 298
34 Limitations of Serum Ferritin in Diagnosing Iron Deficiency in Inflammatory Conditions Axel U Dignass, Karima Farrag, Jürgen M. Stein · International Journal of Chronic Diseases Open access 2018 288
35 European Crohn’s and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn’s Disease Florian Rieder, Giovanni Latella, Fernando Magro et al. · Journal of Crohn s and Colitis Open access 29 Feb 2016 266
36 Treatment of invasive fungal infections in cancer patients—updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO) Sabine Mousset, Dieter Buchheidt, Werner Heinz et al. · Annals of Hematology Open access 11 Sep 2013 255
37 20-Jahres-Ergebnisse einer 5‑jährigen Hormontherapie bei Mammakarzinom Lena Traub, Marc Thill, Sirka Nitschmann · Der Internist 2 Mar 2018 253
38 The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction – a phase III trial of the German AIO/CAO-V/CAOGI Salah‐Eddin Al‐Batran et al. · BMC Cancer Open access Dec 2017 235
39 EAES recommendations for the management of gastroesophageal reflux disease K.-H. Fuchs, Benjamin Babic, Wolfram Breithaupt et al. · Surgical Endoscopy May 2014 235
40 Left Atrial Appendage Closure after Ablation for Atrial Fibrillation Oussama M. Wazni et al. · New England Journal of Medicine Open access 16 Nov 2024 224
41 Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial Sylvie Lorenzen et al. · Journal of Clinical Oncology 14 Nov 2023 224
42 Genome-Wide Screen for Metabolic Syndrome Susceptibility Loci Reveals Strong Lipid Gene Contribution But No Evidence for Common Genetic Basis for Clustering of Metabolic Syndrome Traits Kati Kristiansson et al. · Circulation Cardiovascular Genetics Open access 8 Mar 2012 211
43 Comparison of different rating scales for the use in Delphi studies: different scales lead to different consensus and show different test-retest reliability Toni Lange, Christian Kopkow, Jörg Lützner et al. · BMC Medical Research Methodology Open access 10 Feb 2020 210
44 The Central-European SentiMag study: Sentinel lymph node biopsy with superparamagnetic iron oxide (SPIO) vs. radioisotope Marc Thill, Andrzej Kurylcio, Rebekka Welter et al. · The Breast Open access 30 Jan 2014 198
45 In vivo chemosensitivity-adapted preoperative chemotherapy in patients with early-stage breast cancer: the GEPARTRIO pilot study Gϋnter von Minckwitz, Jens‐Uwe Blohmer, Günther Raab et al. · Annals of Oncology Open access 14 Dec 2004 196
46 Aktualisierte S3-Leitlinie – „Diagnostik und Therapie des Morbus Crohn“ 2014 J. Preiß, Bernd Bokemeyer, Heinz Johannes Buhr et al. · Zeitschrift für Gastroenterologie 4 Dec 2014 188
47 Aktualisierte Leitlinie zur Diagnostik und Therapie der Colitis ulcerosa 2011 – Ergebnisse einer Evidenzbasierten Konsensuskonferenz Axel U. Dignass et al. · Zeitschrift für Gastroenterologie Open access 24 Aug 2011 179
48 Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease Stefan Schreiber, Axel U Dignass, Laurent Peyrin‐Biroulet et al. · Journal of Gastroenterology ReviewOpen access 4 Jun 2018 177
49 Left atrial appendage occlusion with the AMPLATZER Amulet device: one-year follow-up from the prospective global Amulet observational registry Ulf Landmesser, Claudio Tondo, A. John Camm et al. · EuroIntervention Aug 2018 175
50 Per-oral endoscopic myotomy white paper summary Stavros Nicholas Stavropoulos, David J. Desilets, Karl‐Hermann Fuchs et al. · Gastrointestinal Endoscopy Open access 17 Jun 2014 173

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.